21 publications
| Name | Date | Type | Actions |
|---|---|---|---|
Monthly information regarding the total number of voting rights and shares making of the share capital - December2018 As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » |
08/01/2019 | Voting rights | |
2018 sales: up 3.2% to €367.9 million 9.1% GROWTH IN ESSENTIALS PRODUCTS AT CONSTANT EXCHANGE RATES
|
24/01/2019 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - January 2019 As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » |
06/02/2019 | Voting rights | |
Monthly information regarding the total number of voting rights and shares making of the share capital - February 2019 As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » |
05/03/2019 | Voting rights | |
Growth in all financial indicators in 2018. Essentials products sales: €179.4M (up 9.1% at constant exchange rates). Net income group share €36.3M (up 4.0%) At its meeting on March 19, 2019, the Vetoquinol S.A. Board of Directors reviewed the Group results and approved the audited 2018 financial statements. |
20/03/2019 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - MArch 2019 As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » |
03/04/2019 | Voting rights | |
Vetoquinol signs agreement to acquire Clarion Biociênciasin Brazil On April 3rd, Vetoquinol signed an agreement to acquire Clarion Biociências, a Brazilian veterinary laboratory based in the state of Goiás. |
04/04/2019 | Public releases | |
Vetoquinol finalizes acquisition of Clarion Biociencias in Brazil Lure (France), April 16, 2019 - Vetoquinol today confirms the completion of its acquisition of Clarion Biociências, a Brazilian veterinary laboratory based in the state of Goiás.
|
16/04/2019 | Public releases | |
Q1 2019 sales: €90.9 million (up 3.7%) Vetoquinol Group sales for Q1 2019 amounted to €90.9 million, up 2.3% at constant exchange rates and up 3.7% as reportedfrom the same period last year. |
17/04/2019 | Public releases | |
Vetoquinol publishes its registration document and its annual financial report relative to fiscal year 2018 (french version) The registration document of Vetoquinol relative to fiscal year 2018, including the annual financial report relative to fiscal year 2018, was filed with the Autorité des marchés financiers (“the AMF”) on April 29, 2019.
|
29/04/2019 | Public releases |